SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech fireworks -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (1034)6/12/2003 9:41:36 AM
From: nigel bates  Read Replies (1) | Respond to of 7424
 
POZN 27% on GSK deal.



To: Jibacoa who wrote (1034)6/12/2003 9:18:11 PM
From: Jibacoa  Read Replies (1) | Respond to of 7424
 
CRIS closed up 28% and volume was over 7.5M

On their deal with DNA (they licensed their inhibitors of the Hedgehog signaling pathway), they are supposed to get an $8.5M licensing agreement and DNA is to pay CRIS additional fees over the next two years, as well as future milestone and royalty payments.

The stock didn't close its initial up-gap, and managed to close at another 52wks H. (The June 10 H was 4.53)

siliconinvestor.com

siliconinvestor.com

Bernard